- Home
- Publications
- Publication Search
- Publication Details
Title
Meeting the needs of CML patients in resource-poor countries
Authors
Keywords
-
Journal
Hematology-American Society of Hematology Education Program
Volume 2019, Issue 1, Pages 433-442
Publisher
American Society of Hematology
Online
2019-12-06
DOI
10.1182/hematology.2019000050
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chronic Myeloid Leukemia: Long-Term Outcome Data in the Imatinib Era
- (2018) Prasanth Ganesan et al. INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION
- Imatinib trough levels: a potential biomarker to predict cytogenetic and molecular response in newly diagnosed patients with chronic myeloid leukemia
- (2018) Harivenkatesh Natarajan et al. LEUKEMIA & LYMPHOMA
- Paper or plastic? BCR-ABL1 quantitation and mutation detection from dried blood spots
- (2016) O. Sala Torra et al. BLOOD
- Pioglitazone together with imatinib in chronic myeloid leukemia: A proof of concept study
- (2016) Philippe Rousselot et al. CANCER
- Comprehensive Evaluation of Adherence to Therapy, Its Associations, and Its Implications in Patients With Chronic Myeloid Leukemia Receiving Imatinib
- (2016) Radhika Unnikrishnan et al. Clinical Lymphoma Myeloma & Leukemia
- Population-based assessment of chronic myeloid leukemia in Sweden: striking increase in survival and prevalence
- (2016) Niklas Gunnarsson et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population
- (2016) Hannah Bower et al. JOURNAL OF CLINICAL ONCOLOGY
- Anti-leukemic activities of alcoholic extracts of two traditional Indian medicinal plants
- (2015) Shipra Bhargava et al. LEUKEMIA & LYMPHOMA
- TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets
- (2014) D. T. Yeung et al. BLOOD
- Cultural factors related to adherence to imatinib in CML: A Mexican perspective
- (2014) Olga Graciela Cantú-Rodríguez et al. Hematology
- Response to tyrosine kinase inhibitors in chronic myeloid leukemia: experience from a west Asian developing country
- (2014) Mohammed Dhahir Ali et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Correlation of plasma trough levels of imatinib with molecular response in patients with chronic myeloid leukemia
- (2014) Hemant Malhotra et al. LEUKEMIA & LYMPHOMA
- Generic imatinib: the real-deal or just a deal?
- (2014) Vikram Mathews LEUKEMIA & LYMPHOMA
- Regional variations in age at diagnosis and overall survival among patients with chronic myeloid leukemia from low and middle income countries
- (2013) Adam M. Mendizabal et al. Cancer Epidemiology
- Diagnostic point-of-care tests in resource-limited settings
- (2013) Paul K Drain et al. LANCET INFECTIOUS DISEASES
- The EUTOS prognostic score: review and validation in 1288 patients with CML treated frontline with imatinib
- (2013) V S Hoffmann et al. LEUKEMIA
- Success Story of Targeted Therapy in Chronic Myeloid Leukemia: A Population-Based Study of Patients Diagnosed in Sweden From 1973 to 2008
- (2011) Magnus Björkholm et al. JOURNAL OF CLINICAL ONCOLOGY
- Evaluation of Two Commercial Loop-Mediated Isothermal Amplification Assays for Detection of Avian Influenza H5 and H7 Hemagglutinin Genes
- (2011) Alexander Postel et al. JOURNAL OF VETERINARY DIAGNOSTIC INVESTIGATION
- Quantifying HIV for Monitoring Antiretroviral Therapy in Resource‐Poor Settings
- (2010) Wendy S. Stevens et al. JOURNAL OF INFECTIOUS DISEASES
- Benefits of global partnerships to facilitate access to medicines in developing countries: a multi-country analysis of patients and patient outcomes in GIPAP
- (2010) Panos Kanavos et al. Globalization and Health
- Chronic myeloid leukemia in Asia
- (2008) Wing Y. Au et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started